Fig. 4From: Prediction of the active compounds and mechanism of Biochanin A in the treatment of Legg-Calvé-Perthes disease based on network pharmacology and molecular dockingGO enrichment analysis. The top 100 key targets in PPI network were selected for GO enrichment analysisBack to article page